{"disease":{"id":"newly-diagnosed-acute-myeloid-leukemia-with-high-risk","name":"newly diagnosed acute myeloid leukemia with high risk"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06810791","title":"HVA vs IA/DA or VA in the Treatment of ND HR-AML","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":876,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}